Koninklijke Philips reported EUR9.78B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Baxter International USD 6.99B 142M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Boston Scientific USD 7.97B 712M Jun/2026
Danaher USD 13.38B 554M Jun/2026
Demant DKK 10.08B 128M Dec/2025
Dexcom USD 4.09B 245.1M Jun/2026
Edwards Lifesciences USD 6.82B 590.2M Jun/2026
Fresenius EUR 11.61B 456M Jun/2026
General Electric Aerospace USD 39.7B 664M Jun/2026
Getinge SEK 15.77B 2.39B Jun/2026
Globus Medical USD 2.22B 17.39M Jun/2026
GN Store Nord DKK 4.85B 3.79B Mar/2026
Hitachi JPY 7.84T 26.97B Jun/2026
Idexx Laboratories USD 1.51B 55.41M Jun/2026
Insulet USD 1.85B 139.6M Jun/2026
Integra LifeSciences USD 1.19B 19.46M Jun/2026
Intuitive Surgical USD 12.33B 807.5M Jun/2026
J&J USD 59.77B 601M Jun/2026
Koninklijke Philips EUR 9.78B 1.88B Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Philips EUR 9.33B 454M Jun/2026
ResMed USD 4.32B 260.68M Jun/2026
Smith & Nephew USD 4.39B 240M Jun/2026
Steris USD 2.45B 51.2M Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Teleflex USD 1.88B 16.21M Jun/2026
Terumo JPY 906.6B 45.57B Jun/2026
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026